Literature DB >> 9882526

Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.

B Ringelmann1, C Röder, R Hallmann, M Maley, M Davies, M Grounds, L Sorokin.   

Abstract

The dy/dy mouse is an animal model for human merosin-negative congenital muscular dystrophy (CMD), which has been reported to have reduced or no expression of the basement membrane protein laminin alpha2. We here investigate various myogenic and nonmyogenic tissues of mature dy/dy and control 129ReJ mice histologically and for laminin alpha2 expression. In addition, expression patterns of laminin alpha1, alpha2, alpha4, and alpha5 chains, the interstitial proteins fibronectin and tenascin-C, and the adhesion molecules VCAM-1, ICAM-1, and alpha4 integrin were characterized in skeletal muscle of 1- and 7-day and mature (>6 weeks old) dy/dy and control 129ReJ mice. The laminin alpha2 chain remained detectable in myogenic tissues of dy/dy mice by immunofluorescence using two different monoclonal antibodies and by Northern blot analysis. However, laminin alpha2 expression was significantly reduced or not detectable in nonmyogenic tissues of dy/dy mice, including skin, lung, kidney, brain, thymus, and eye. Focal lesions were observed in mature skeletal muscle only, characterized by necrotic tissue, isolated VCAM-1- and ICAM-1-positive cells indicative of inflammatory processes, and regenerating muscle fibers surrounded by intense tenascin-C and fibronectin expression. In contrast to studies on human CMD muscle, laminin alpha1 was not detectable in either dy/dy or control skeletal muscle using immunofluorescence or Northern blot analysis. Immunofluorescence localized laminin alpha4 to basement membranes of blood vessels, the endoneurium of the intramuscular nerves, and the neuromuscular junction in skeletal muscle of 1- and 7-day-old dy/dy and control mice. In mature muscle, laminin alpha4 expression shifted to the perineurium of intramuscular nerves in both dy/dy and control mice. Furthermore, strong upregulation of laminin alpha4 in the basement membranes of blood vessels, the perineurium of intramuscular nerves, and of isolated regenerating muscle fibers in the dy/dy mice was apparent. Investigation of 1-day-old animals revealed expression of laminin alpha5 in skeletal muscle fiber basement membranes of dy/dy but not control animals. This difference between dy/dy and control animals was no longer apparent at 7 days after birth, indicating a temporary shift in expression pattern of laminin alpha5 in dy/dy animals. Analysis of the extracellular matrix components of 1- and 7-day-old dy/dy and control skeletal muscle revealed an early onset of the dystrophy, even before histopathological features of the disease were evident. Our data confirm the absence of laminin alpha1 chain in myogenic tissues of both dy/dy and control mice and suggest compensation for reduced laminin alpha2 in dy/dy skeletal muscle by laminin alpha4 and, in early development, also laminin alpha5. These results have significant ramifications in the diagnosis of human merosin-negative CMD. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882526     DOI: 10.1006/excr.1998.4244

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  39 in total

1.  Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle.

Authors:  Katherine E Wardrop; Janice A Dominov
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

2.  Deletion of the laminin alpha4 chain leads to impaired microvessel maturation.

Authors:  Jill Thyboll; Jarkko Kortesmaa; Renhai Cao; Raija Soininen; Ling Wang; Antti Iivanainen; Lydia Sorokin; Mårten Risling; Yihai Cao; Karl Tryggvason
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 3.  Laminin-211 in skeletal muscle function.

Authors:  Johan Holmberg; Madeleine Durbeej
Journal:  Cell Adh Migr       Date:  2012-11-15       Impact factor: 3.405

4.  Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.

Authors:  Chunping Qiao; Jianbin Li; Tong Zhu; Romesh Draviam; Simon Watkins; Xiaojing Ye; Chunlian Chen; Juan Li; Xiao Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

5.  Venular basement membranes ubiquitously express matrix protein low-expression regions: characterization in multiple tissues and remodeling during inflammation.

Authors:  Mathieu-Benoît Voisin; Doris Pröbstl; Sussan Nourshargh
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Comparative Analysis of the Extracellular Matrix Proteome across the Myotendinous Junction.

Authors:  Kathryn R Jacobson; Sarah Lipp; Andrea Acuna; Yue Leng; Ye Bu; Sarah Calve
Journal:  J Proteome Res       Date:  2020-09-14       Impact factor: 4.466

7.  Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.

Authors:  Kinga I Gawlik; Mikael Akerlund; Virginie Carmignac; Harri Elamaa; Madeleine Durbeej
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

8.  Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.

Authors:  Miao Yu; Yonglin He; Kejian Wang; Peng Zhang; Shengle Zhang; Huaiyu Hu
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

9.  Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier.

Authors:  Willias Masocha; Brita Robertson; Martin E Rottenberg; Jama Mhlanga; Lydia Sorokin; Krister Kristensson
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.

Authors:  Eleni Bazigou; Sherry Xie; Chun Chen; Anne Weston; Naoyuki Miura; Lydia Sorokin; Ralf Adams; Andrés F Muro; Dean Sheppard; Taija Makinen
Journal:  Dev Cell       Date:  2009-08       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.